The 5-FU Holter Study
To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy
| Condition(s) | Gastrointestinal Malignancy |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | To assess the feasibility of using ambulatory ECG monitoring (Holter monitor) for patients receiving 5-FU chemotherapy |
| Who can participate | Inclusion Criteria: * Patients with diagnosis of gastrointestinal malignancy * Planned to receive either FOLFOX chemotherapy with any treatment intent * Aged ≥ 18 years at time of signing informed consent form Exclusion Criteria: • ECG with left bundle branch block or left ventricular hypertrophy with strain |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Auckland, New Zealand |
| Locations | Auckland, New Zealand |
| Start date | 2024-11-01 |
| NCT ID | NCT06538610 |
| Official listing | https://clinicaltrials.gov/study/NCT06538610 |